Sienna Biopharmaceuticals, Inc. — Form D

Sienna Biopharmaceuticals, Inc. of Weslake Village, CA, a company, filed a Form D exempt-offering notice with the SEC on 2017-05-15. The offering totals $40.5M, of which $40.5M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (21)

NameRoleLocation
Frederick C Beddingfield IIIDirectorWestlake Village, CA
Kristina R BurowDirectorWestlake Village, CA
Dennis R FentonDirectorWestlake Village, CA
Todd C HarrisDirectorWestlake Village, CA
Keith R Leonard Jr.DirectorWestlake Village, CA
Bob R MoreDirectorWestlake Village, CA
Robert R NelsenDirectorWestlake Village, CA
Timothy K AndrewsExecutive OfficerSan Diego, CA
Frederick C Beddingfield IIIExecutive OfficerWestlake Village, CA
Todd C HarrisExecutive OfficerWestlake Village, CA
Paul F LizzulExecutive OfficerWestlake Village, CA
Ric C PetersonExecutive OfficerWestlake Village, CA
Diane F StroehmannExecutive OfficerWestlake Village, CA
Robert NelsonDirectorShreveport, LA
Kristina BurowDirectorSan Diego, CA
Robert MoreDirectorCarlsbad, CA
Robert MoreExecutive OfficerCarlsbad, CA
Todd HarrisDirectorSan Juan Capistrano, CA
Todd HarrisExecutive OfficerSan Juan Capistrano, CA
Ted SchwarzExecutive OfficerCarlsbad, CA
Frederick BeddingfieldDirectorCarlsbad, CA

Other filings by this issuer (2)

FiledFormOfferingSold
2017-05-15D/A$50.0M$46.6M
2015-10-20D$40.4M$18.5M

More